-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2020 to Q4 2023.
- LENZ Therapeutics, Inc. Depreciation for the quarter ending December 31, 2023 was $100K, a 85.7% decline year-over-year.
- LENZ Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2023 was $2.4M, unchanged year-over-year.
- LENZ Therapeutics, Inc. annual Depreciation for 2023 was $2.4M, unchanged from 2022.
- LENZ Therapeutics, Inc. annual Depreciation for 2022 was $2.4M, a 243% increase from 2021.
- LENZ Therapeutics, Inc. annual Depreciation for 2021 was $700K, a 600% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)